Evidence map›Paper›PMID 25101070›Full record

ArticleFrontiers in microbiology2014

Rescue of mutant fitness defects using in vitro reconstituted designer transposons in Mycoplasma mycoides.

Bogumil J Karas, Kim S Wise, Lijie Sun, J Craig Venter, John I Glass, Clyde A Hutchison, Hamilton O Smith, Yo Suzuki

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. iScience · 2026
    Article
  2. Live imaging of bacterial actin MreBs fromBiophysics and physicobiology · 2026
    Article
  3. Article
  4. Frontiers in genetics · 2024
    Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Strategies for cloning and manipulating natural and synthetic chromosomes.Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Bogumil J KarasDepartment of Synthetic Biology and Bioenergy, J. Craig Venter Institute La Jolla, CA, USA.
Kim S WiseDepartment of Synthetic Biology and Bioenergy, J. Craig Venter Institute La Jolla, CA, USA ; Department of Molecular Microbiology and Immunology, University of Missouri Columbia, MO, USA.
Lijie SunDepartment of Synthetic Biology and Bioenergy, J. Craig Venter Institute La Jolla, CA, USA.
J Craig VenterDepartment of Synthetic Biology and Bioenergy, J. Craig Venter Institute La Jolla, CA, USA ; Department of Synthetic Biology and Bioenergy, J. Craig Venter Institute Rockville, MD, USA.
John I GlassDepartment of Synthetic Biology and Bioenergy, J. Craig Venter Institute La Jolla, CA, USA ; Department of Synthetic Biology and Bioenergy, J. Craig Venter Institute Rockville, MD, USA.
Clyde A HutchisonDepartment of Synthetic Biology and Bioenergy, J. Craig Venter Institute La Jolla, CA, USA.
Hamilton O SmithDepartment of Synthetic Biology and Bioenergy, J. Craig Venter Institute La Jolla, CA, USA.
Yo SuzukiDepartment of Synthetic Biology and Bioenergy, J. Craig Venter Institute La Jolla, CA, USA.
J. Craig Venter Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With only hundreds of genes contained within their genomes, mycoplasmas have become model organisms for precise understanding of cellular processes, as well as platform organisms for predictable engineering of microbial functions for mission-critical applications. Despite the availability of "whole genome writing" in Mycoplasma mycoides, some traditional methods for genetic engineering are underdeveloped in mycoplasmas. Here we demonstrate two facile transposon-mediated approaches for introducing genes into the synthetic cell based on M. mycoides. The marker-less approach involves preparing a fragment containing only a small genomic region of interest with flanking transposase-binding sites, followed by in vitro transposase loading and introduction into the cells. The marker-driven approach involves cloning an open reading frame (ORF) of interest into a vector containing a marker for mycoplasma transformation, as well as sites for transposase loading and random genomic integration. An innovative feature of this construct is to use a single promoter to express the transformation marker and the introduced ORF. The marker-driven approach can be conveniently applied to any exogenous or synthetic gene without any information on the effect of the gene on the strain, whereas the marker-less approach requires that the fragment has a recognizable effect. Using the marker-less method, we found that a region containing the nusG gene rescues a slow growth phenotype of a strain containing a larger deletion encompassing this gene. Using the marker-driven approach, we better defined this finding, thereby establishing that nusG is required for a normal growth rate in synthetic M. mycoides. These methods are suitable for complementation tests to identify genes responsible for assorted functions lacking in deletion mutants. These approaches are also expected to facilitate rapid testing of various natural and engineered genes or gene clusters from numerous sources in M. mycoides.

Indexed as

complementationminimal cellnusGsynthetic celltransposome

Identifiers

PMID25101070
PMCPMC4107850
OpenAlexW2049597558

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.